قالب وردپرس درنا توس
Home / Health / Regeneron stopped recruiting critically ill COVID-19 patients for antibody testing

Regeneron stopped recruiting critically ill COVID-19 patients for antibody testing



Regeneron Pharmaceuticals halted enrollment of critically ill COVID-19 patients during a study of antibody cocktail treatments that were presented to President Trump earlier this month. This decision is due to potential safety concerns.

Drug manufacturers on Friday to speak They suspended admission of patients with COVID-19 hospitalized requiring high-flow oxygen or mechanical ventilation after an independent monitoring committee found “a potential safety signal and a risk / benefit profile. disadvantage at this point.


Our country is in a historic war against Coronavirus. Add your American change to your Facebook or Twitter feed to stay up to date on news.


The enrollment of patients in this category will be suspended pending additional data collection and analysis.

Trials will continue to check the antibody mix in hospitalized patients who need little or no additional oxygen. Further trials involving patients with mild or moderate illness may also continue.

The drug has given encouraging results. Regeneron on Wednesday said preliminary data showed that this therapy reduced the number of COVID-1

9 related visits by 57%.

Earlier this month, Regeneron asked the Food and Drug Administration for emergency approval and said it would provide the dosage free of charge to Americans. The drugmaker said it could have enough doses for 300,000 people in the coming months.

On Monday, a study of Eli Lilly monoclonal antibodies in hospitalized patients was halted after it was discovered that the treatment did not provide any benefit to COVID-19 patients.

Earlier this month, Trump was given a single 8-gram dose of Regeneron’s experimental treatment under a charity request and noted the drug helped him overcome his illness.


THINGS YOU NEED TO KNOW ABOUT CORONAVIRUS RIGHT NOW

HOW TO READ CORONAVIRUS’S THIRD WALLS AND WINTER

SAYING IN NON-NEED CASE ‘NOT ONLY TEST FUNCTION’, CHECK CZAR SAID IN CONTRACT TO TRUMP

HOW TO READ CORONAVIRUS’S THIRD WALLS AND WINTER

MASK FACILITY CAN SAVE MORE THAN 100,000 LIFE IN NEXT MONTHS AND YEARS: NEW SCHOOL

Smart sensors can be a high-tech solution to enhance society in offices





Source link